Pharmafile - Medical Communications News
In the last week, a number of new developments have made the news; for COVID-19, the Oxford-AstraZeneca vaccine has been suspended in 11 European...
The Russian Direct Investment Fund (RDIF) and Stelis Biopharma have today announced a partnership which aims to produce and supply a minimum of 200...
A new second line triple therapy is to be offered to NHS patients in England with multiple myeloma, following a NICE recommendation announced today.
AstraZeneca’s COVID-19 vaccine has been cleared for continued use by the EMA following an investigation into the reports of 37 thromboembolic events...
A new precision drug combination, olaparib with bevacizumab, will now be available on the Cancer Drugs Fund (CDF) for ovarian cancer treatment...
In the last week, a number of new treatment developments have made the news; for COVID-19, GSK and Vir’s monoclonal-antibody drug has been found to...
Kintor Pharmaceutical’s Proxalutamide treatment has been proven to reduce risk of mortality from COVID-19 by 92%, in a clinical trial conducted on...
The European Commission has granted Johnson and Johnson’s single-shot COVID-19 vaccine Conditional Marketing Authorisation (CMA), it was announced...
Novavax has announced final efficacy of 96.4% against mild, moderate, and severe disease caused by the original COVID-19 strain in a pivotal UK...
Altimmune has expanded its previously-announced AdCOVID vaccine manufacturing collaboration with Lonza.
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches
